The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?-Reference-Cited by-同舟云学术

The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?

Published:2023-07 Issue: Volume:174 Page:121-128
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Witjes Vera M.,Ligtenberg Marjolijn J.L.,Vos Janet R.,Braspenning Jozé C.C.,Ausems Margreet G.E.M.,Mourits Marian J.E.,de Hullu Joanne A.,Adang Eddy M.M.,Hoogerbrugge Nicoline

Funder

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition;Vos;JNCI,2019

2. Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: a systematic review;Arts-de Jong;Eur. J. Cancer,2016

3. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ∼30,000 cases;Suszynska;J. Ova. Res.,2020

4. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer;Moore;N. Engl. J. Med.,2018

5. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer;Mirza;N. Engl. J. Med.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers;Gynecologic Oncology;2024-08

2. Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow;Familial Cancer;2024-05-29

3. BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study;Cancers;2024-04-26

4. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study;Swiss Medical Weekly;2024-04-15

5. Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer;Cancers;2023-12-29